https://www.forbes.com/sites/r....oberthart/2024/09/04

Moderna’s mRNA Mpox Vaccine Beats Licensed Rivals In Early Test
www.forbes.com

Moderna’s mRNA Mpox Vaccine Beats Licensed Rivals In Early Test

The experimental mRNA shot, tested in macaques, generated a stronger immune response and dramatically reduced the number of mpox lesions in infected animals compared to Bavarian Nordic’s licensed vaccine, Jynneos.
image
image
image
image